Skip to content
CLADsolve

Paper

Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction

Evidence level: human cohorts (two plus one); abstract-only

Airway pepsinogen A4, which is made in stomach but not lung, marked microaspiration and predicted CLAD in two independent cohorts of recipients.

As of . Primary source: Publisher record via DOI.

Summary

The authors compared expression of pepsinogens in lung tissue, measured total pepsin and pepsinogen A4 (PGA4) in large airway bronchial washings, and assessed CLAD in two independent cohorts of lung transplant recipients, with a third cohort used for antireflux surgery. According to the abstract, PGA4 was expressed in healthy human stomach but not lung; airway PGA4, but not total pepsin, was associated with aspiration; airway PGA4 was associated with increased CLAD risk in both cohorts; and antireflux surgery was associated with reduced airway PGA4. The authors propose measuring PGA4 at surveillance bronchoscopy to triage high-risk recipients for antireflux surgery. Cohort sizes are not stated in the abstract.

Details

doi
10.1016/j.healun.2024.01.002
pmid
38211836
authors
Ramendra R, Duong A, Zhang CYK, Huszti E, Zhou X, Havlin J, Ghany R, Cypel M, Yeung JC, Keshavjee S, Sage AT, Martinu T
journal
The Journal of Heart and Lung Transplantation
year
2024
volume
43
issue
6
pages
973-982

Sources and links

Related

Links from this record

Linked from (derived)

Known gaps in this record

  • full text not read (abstract only)
  • funding statement and grant numbers
  • cohort sizes

Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.